−0.025 CAD
−929.07 K CAD
0.00 CAD
About RIZE ONCOLOGY INC.
Sector
Industry
CEO
Roland Boivin
Website
Headquarters
Kelowna
Founded
2018
FIGI
BBG014XHHT68
Rize Oncology, Inc. is a genetic medicines company, which engages in the creation of gene editing therapies based on the GeneTether platform. The company was founded by Daren Graham, William J. Garner, and R. Geoffrey Sargent on February 12, 2018 and is headquartered in Kelowna, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of RIZE is 0.100 CAD — it has increased by 33.33% in the past 24 hours. Watch RIZE ONCOLOGY INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on CSE exchange RIZE ONCOLOGY INC. stocks are traded under the ticker RIZE.
RIZE stock has risen by 33.33% compared to the previous week, the month change is a 166.67% rise, over the last year RIZE ONCOLOGY INC. has showed a 150.00% increase.
RIZE stock is 20.00% volatile and has beta coefficient of 5.32. Track RIZE ONCOLOGY INC. stock price on the chart and check out the list of the most volatile stocks — is RIZE ONCOLOGY INC. there?
Yes, you can track RIZE ONCOLOGY INC. financials in yearly and quarterly reports right on TradingView.
RIZE net income for the last quarter is −175.59 K CAD, while the quarter before that showed −147.48 K CAD of net income which accounts for −19.06% change. Track more RIZE ONCOLOGY INC. financial stats to get the full picture.
No, RIZE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RIZE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RIZE ONCOLOGY INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RIZE ONCOLOGY INC. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RIZE ONCOLOGY INC. stock shows the buy signal. See more of RIZE ONCOLOGY INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.